Human Genome Sciences to deploy Aegis Analytical's Discoverant manufacturing intelligence solution

Download PDF Copy

Mar 17 2010

NewsGuard 100/100 Score

Aegis Analytical Corp., the leading provider of Enterprise Manufacturing Intelligence software, announced today that Human Genome Sciences, Inc. will deploy Aegis’ Discoverant^® as its data management, analytics and reporting solution in the scale-up and production of BENLYSTA™ (belimumab), an investigational drug for the treatment of systemic lupus that has successfully completed Phase 3 trials. The submission of marketing applications for BENLYSTA is planned in the U.S., Europe and other regions in the second quarter of 2010.

Source Human Genome Sciences

Posted in: Drug Trial News | Device / Technology News | Medical Condition News

Tags: Anthrax, Cancer, Genome, Hepatitis C, Lupus, Manufacturing, Software

Comments (0)

Download PDF Copy

Suggested Reading

Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing

Cellular Origins, Fresenius Kabi sign development agreement for scalable automation of cell and gene therapy manufacturing

Step up your cosmetics manufacturing with OHAUS!

Step up your cosmetics manufacturing with OHAUS!

Utilizing process Raman in optimizing cultivated meat production

Utilizing process Raman in optimizing cultivated meat production

From crude lysate to purity with high-precision AAV capsid measurement with Bio-Rad's new ddPCR Kit

From crude lysate to purity with high-precision AAV capsid measurement with Bio-Rad's new ddPCR Kit

Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment

Scientists uncover cerebrospinal fluid markers for Alzheimer's detection and treatment

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

Genetic risk factors for long-COVID uncovered in a large multi-ethnic study

Stem-cell implants restore vision in patients with corneal stem cell deficiency

Stem-cell implants restore vision in patients with corneal stem cell deficiency

Rare variant analysis reveals genetic spectrum of monogenic diabetes genes

Rare variant analysis reveals genetic spectrum of monogenic diabetes genes

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

AHN Biotechnologie GmbH – Premium private label manufacturing biotechnology